
GUARDIAN PHRMCY SERVICES-A
GRDNNYSETrading Snapshot
- Day Range
- $122.11 β $124.00
- 52-Week Range
- $19.30 β $47.02
- Volume
- $3.06B
- Avg Volume
- $3.27B
- Shares Outstanding
- 63.3M
- Next Earnings
- Sep 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.45B
- Last Q Revenue
- $352M
- P/E Ratio
- 49.5
- P/S Ratio
- 1.8x
- EPS (TTM)
- $0.82
- Dividend Yield
- β
Why Investors Own GRDN
- βHigh-growth profile β revenue up +35.2% YoY with expanding US Equity exposure.
- βHealthy economics β 77% gross margin and 27% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About GUARDIAN PHRMCY SERVICES-A
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
GUARDIAN PHRMCY SERVICES-A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift GRDN price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
GUARDIAN PHRMCY SERVICES-A announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.